NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines

The RET fusion is considered as the potential novel target in solid tumors. However, RET fusion is not well yet identified in colorectal cancer (CRC), and the effect of RET kinase inhibitor is also not evaluated in CRC with RET fusion. We established patient-derived tumor cells (PDCs) with RET fusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sun Young, Oh, Seiyoon Oh, Kim, Kyung, Lee, Jeeyun, Kang, SoYoung, Kim, Kyoung-Mee, Lee, WooYong, Kim, Seung Tae, Nam, Dohyun Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134812/
https://www.ncbi.nlm.nih.gov/pubmed/30210625
http://dx.doi.org/10.7150/jca.26256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134812/
https://www.ncbi.nlm.nih.gov/pubmed/30210625
http://dx.doi.org/10.7150/jca.26256

Ejemplares similares